Navigation Links
ADVENTRX Pharmaceuticals Reports Second Quarter Financial Results
Date:8/12/2009

armaceuticals

ADVENTRX Pharmaceuticals is a biopharmaceutical company whose product candidates are designed to improve the safety of existing cancer treatments. More information can be found on the Company's website at www.adventrx.com.

Forward Looking Statements

ADVENTRX cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that involve risks and assumptions that, if they materialize or do not prove to be accurate, could cause ADVENTRX's results to differ materially from historical results or those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: the risk that ADVENTRX will be unable to raise sufficient additional capital on a timely basis to submit an NDA for ANX-530, to fund operations or pre-launch activities during the FDA review period if an NDA is submitted or launch activities should an NDA for ANX-530 be approved; the risk that ADVENTRX will be unable to raise sufficient additional capital on a timely basis to continue as a going concern; the risk that ADVENTRX will seek protection under the provisions of the U.S. Bankruptcy Code; the risk that ADVENTRX will reassess the results of the ANX-530 bioequivalence study and determine to conduct additional bioequivalence studies of ANX-530, including in humans; the potential for regulatory authorities to require additional preclinical work and/or clinical activities to support regulatory filings, including prior to the submission or the approval of an NDA for ANX-530, which activities may increase the cost and timeline to NDA submission or approval; the risk the FDA will determine that ANX-530 and Navelbine(R) are not bioequivalent, including as a result of performing pharmacokinetic equivale
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
2. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. ADVENTRX Pharmaceuticals to Present at the 20th Annual Bear Stearns Healthcare Conference
4. ADVENTRX Announces ANX-514 Clinical Development Plan Affirmed by the FDA
5. ADVENTRX Pharmaceuticals to Present at the ThinkEquity Partners Fifth Annual Growth Conference
6. ADVENTRX Pharmaceuticals to Present at the 2007 UBS Global Life Sciences Conference
7. ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference
8. ADVENTRX Pharmaceuticals to Present at the 2007 BIOInvestor Forum
9. ADVENTRX Appoints Vice President of Commercialization
10. ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results
11. ADVENTRX Announces Consolidation of Clinical and Management Positions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... RURO, Inc., a leading LIMS, RFID ... – the latest update to the bestselling commercial-off-the-shelf sample ... a quick and easy method to gain better control ... RURO engineering has enhanced the system’s support for those ... of sample records. , "FreezerPro has become the ...
(Date:2/26/2015)... 26, 2015 Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" ... interests in the natural wellness sector and in developing ... its products will be featured at the SEC Compliance ... th Annual Growth Stock Conference on March 8-11 ... Ritz Carlton Drive, Dana Point , ...
(Date:2/26/2015)... New York (PRWEB) February 26, 2015 ... organization dedicated to building a nationwide Clostridium difficile (C. ... new C. diff burden study by the Centers for ... C. diff caused almost half a million infections among ... in U.S. nursing homes. , The study also ...
(Date:2/25/2015)... Feb. 25, 2015 Today, BioMed Realty Trust, ... including a number of promotions and additions to its ... strategy to increase shareholder returns through strategic investments in ... care industry and the innovation sector. ... Griffin is leaving his role as President and ...
Breaking Biology Technology:RURO Releases FreezerPro® version 6.2 2SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 2SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 3SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 4Peggy Lillis Foundation Lauds CDC's New, More Comprehensive Study on the Burden of C. difficile Infections in the United States 2Peggy Lillis Foundation Lauds CDC's New, More Comprehensive Study on the Burden of C. difficile Infections in the United States 3Peggy Lillis Foundation Lauds CDC's New, More Comprehensive Study on the Burden of C. difficile Infections in the United States 4BioMed Realty Announces Realignment To Leverage Depth Of Life Science Real Estate Expertise And Increase Shareholder Value 2BioMed Realty Announces Realignment To Leverage Depth Of Life Science Real Estate Expertise And Increase Shareholder Value 3BioMed Realty Announces Realignment To Leverage Depth Of Life Science Real Estate Expertise And Increase Shareholder Value 4
... Feb. 17 Dow,AgroSciences LLC, a wholly owned subsidiary ... and the China National Rice Research Institute (CNRRI) of ... research agreement to,combine the strengths of Dow AgroSciences, platform ... "We look forward to working ...
... Pharmaceuticals, Inc. (Nasdaq: SVNT ) announced today ... fourth quarter and year-end 2008 following the close of ... President and David Gionco, Vice President and Chief Financial ... at 10:00 a.m. Eastern Time on February 26, 2009 ...
... Development StrategyCAMBRIDGE, Mass., Feb. 17 The ALS ... 2009 launch of its popular ALS Research 101 ... to inform and update patients, their families and ... develop effective treatments for amyotrophic lateral sclerosis (ALS, ...
Cached Biology Technology:Dow AgroSciences, China National Rice Research Institute Announce Collaboration on Rice Research 2Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2008 Results Conference Call on Thursday, February 26, 2009 2Seminar Will Bring ALS Researchers to Patient Groups 2Seminar Will Bring ALS Researchers to Patient Groups 3
(Date:2/5/2015)... N.C. , Feb. 5, 2015  Marken is ... logistics company and has launched a new marketing campaign ... Logistics Organization (CLO).  The new campaign focuses on ... patient, protocol and shipments. The first headline ... , aligns Marken,s priorities with its client,s priorities. Marken ...
(Date:2/5/2015)... Conn. , Jan. 26, 2015 NXT-ID, Inc. ... the "Company"), a biometric authentication company focused on the ... new corporate website ( http://www.nxt-id.com/ ) as part of ... smart wallet. The Company launched its new consumer website ... Gino Pereira , CEO of NXT-ID said, "Our new ...
(Date:2/5/2015)... SAN FRANCISCO , January 28, 2015 ... Camera Market Analysis, Size And Segment Forecasts To 2020 ... The global IR camera market is expected to reach ... study by Grand View Research, Inc. IR cameras help ... injuries, and are expected to witness surging demand in ...
Breaking Biology News(10 mins):Marken Launches New Patient-Centric Campaign 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3
... wrinkles and hide those pesky grays, but what about ... fix, such as losing muscle mass? Cutting calories early ... the phenomenon in rats. A restricted-calorie diet, ... mitochondrial mishap that may contribute to muscle loss in ...
... This press release is available in French . ... Research Institute of the Jewish General Hospital along with ... Research Institute (OHRI) report a significant breakthrough in the use ... known as oncolytic virotherapy. Their results were published in the ...
... to see a single molecule inside a living cell. ... helping to develop a new technique that will enable ... unprecedented look at the atomic structure of cellular molecules. ... the country and in Germany and Sweden to utilize ...
Cached Biology News:Cutting calories could limit muscle wasting in later years 2Cutting calories could limit muscle wasting in later years 3Viral 'magic bullet' targets cancer cells with help of new compound 2Improving our ability to peek inside molecules 2
uncoupling protein 2 (mitochondrial, proton carrier), mRNA (cDNA clone MGC:19567 IMAGE:4335185), complete cds...
Catch and Release® v2.0 Reversible Immunoprecipitation System...
Request Info...
Estrogen Receptor (ER) Competitor Assay Kits Green for Estrogen Receptors-alpha and -beta (ER-Alpha and ER-Beta) are ideal for screening novel estrogen receptor binding compounds and endocrine disrup...
Biology Products: